Literature DB >> 17203303

PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children.

Ronghua Ni1, Kenji Ihara, Kenichi Miyako, Ryuichi Kuromaru, Mika Inuo, Hitoshi Kohno, Toshiro Hara.   

Abstract

Interaction between Programmed cell death-1 (PD-1), a member of costimulatory molecules, and its receptors Programmed cell Death-1 Ligand 1 (PD-L1) and Programmed cell Death-1 Ligand 2 (PD-L2), play an important role in the negative regulation of immune reactions. It was shown that a polymorphism in a regulatory site of the PD-1 gene was associated with susceptibility to several autoimmune diseases in various ethnic groups, whereas the contribution of the PD-1 gene or its ligand genes to the onset of type 1 diabetes (T1D) mellitus in the Japanese population remains unknown. We first screened PD-1, PD-L1, and PD-L2 genes for polymorphisms in the Japanese population, and then investigated the frequencies of polymorphisms in patients with T1D mellitus in comparison with healthy controls. In total, we identified 26 polymorphic sites within these genes, and then 23 polymorphisms with minor allele frequencies greater than 5% were intensively analyzed for genotyping in the patients and the controls. As a result, allele and genotype frequencies of the polymorphism numbers 2, 3, 4, 5, 6, and 8 in the PD-1 gene were different to some extent between the patients and the controls with P < 0.05, which did not reach statistical significance after the correction of multiple comparisons. Allele or genotype frequencies of any SNPs in the PD-L1 or PD-L2 gene did not show differences between the patients and the controls. The frequencies of the estimated haplotypes, those of which consisted of polymorphism numbers 2, 3, 4, 5, 6, and 8 in the PD-1, were significantly different between the patients and the controls (P = 0.00095). The in vitro assessment for a transcription activity of each haplotype of the PD-1 gene by luciferase assay did not demonstrate a functional difference between the haplotypes. In conclusion, the genetic evaluation by association study demonstrated that the PD-1 gene was a predisposing gene to the development of T1D mellitus in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17203303     DOI: 10.1007/s00439-006-0309-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  38 in total

1.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Authors:  T Okazaki; A Maeda; H Nishimura; T Kurosaki; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group.

Authors:  M Karvonen; M Viik-Kajander; E Moltchanova; I Libman; R LaPorte; J Tuomilehto
Journal:  Diabetes Care       Date:  2000-10       Impact factor: 19.112

Review 3.  Insulin-dependent diabetes mellitus.

Authors:  R Tisch; H McDevitt
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

4.  The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1.

Authors:  M V Prasad Linga Reddy; M Johansson; G Sturfelt; A Jönsen; I Gunnarsson; E Svenungsson; S Rantapää-Dahlqvist; M E Alarcón-Riquelme
Journal:  Genes Immun       Date:  2005-12       Impact factor: 2.676

Review 5.  Genetics of type 1 diabetes mellitus.

Authors:  F Pociot; M F McDermott
Journal:  Genes Immun       Date:  2002-08       Impact factor: 2.676

6.  Descriptive epidemiology of IDDM in Hokkaido, Japan: the Childhood IDDM Hokkaido Registry.

Authors:  N Matsuura; K Fukuda; A Okuno; S Harada; N Fukushima; A Koike; Y Ito; T Hotsubo
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112

7.  Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB.

Authors:  Min-Young Park; Hyun Duk Jang; Soo Young Lee; Kong-Joo Lee; Eunhee Kim
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

8.  Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.

Authors:  Ludmila Prokunina; Leonid Padyukov; Anna Bennet; Ulf de Faire; Björn Wiman; Jonathan Prince; Lars Alfredsson; Lars Klareskog; Marta Alarcón-Riquelme
Journal:  Arthritis Rheum       Date:  2004-06

9.  Impact of genetic and non-genetic factors in type 1 diabetes.

Authors:  Mohammed Iqbal Hawa; Huriya Beyan; Lisa Rebecca Buckley; Richard David Graham Leslie
Journal:  Am J Med Genet       Date:  2002-05-30

10.  Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes.

Authors:  C Nielsen; D Hansen; S Husby; B B Jacobsen; S T Lillevang
Journal:  Tissue Antigens       Date:  2003-12
View more
  29 in total

1.  Polymorphisms in PDCD1 gene are not associated with aplastic anemia in Chinese Han population.

Authors:  Z J Ming; H Hui; M Miao; Y H Qiu; X G Zhang
Journal:  Rheumatol Int       Date:  2011-09-17       Impact factor: 2.631

2.  Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes.

Authors:  R Fujisawa; F Haseda; C Tsutsumi; Y Hiromine; S Noso; Y Kawabata; S Mitsui; J Terasaki; H Ikegami; A Imagawa; T Hanafusa
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

Review 3.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

4.  Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.

Authors:  Farshid Fathi; Batool Zamani; Ahmad Piroozmand; Samaneh Mozafarpoor; Effat Seyedhashemi; Reza ArefNezhad; Hossein Motedayyen
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

5.  Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese population.

Authors:  Yuan Ma; Xiuchun Liu; Jingyan Zhu; Wanhu Li; Liangjun Guo; Xiao Han; Bao Song; Sensen Cheng; Liu Jie
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Association between hepatitis B viral burden in chronic infection and a functional single nucleotide polymorphism of the PDCD1 gene.

Authors:  Linghua Zheng; Dongling Li; Fusheng Wang; Hao Wu; Xiaozhu Li; Junliang Fu; Xinyue Chen; Lizhong Wang; Yang Liu; Shengdian Wang
Journal:  J Clin Immunol       Date:  2010-08-11       Impact factor: 8.317

7.  Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

8.  PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis.

Authors:  Yoshito Ishizaki; Naoko Yukaya; Koichi Kusuhara; Ryutaro Kira; Hiroyuki Torisu; Kenji Ihara; Yasunari Sakai; Masafumi Sanefuji; Judy R Pipo-Deveza; Catherine Lynn T Silao; Benilda C Sanchez; Marissa B Lukban; Aida M Salonga; Toshiro Hara
Journal:  Hum Genet       Date:  2010-04       Impact factor: 4.132

Review 9.  Meta-analysis of genetic polymorphisms in programmed cell death 1. Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility.

Authors:  Y H Lee; S-C Bae; J-H Kim; G G Song
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

Review 10.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.